NCT00063427View on ClinicalTrials.gov

Study Evaluating MAC-321 in Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

Not specified

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms
Interventions
DRUG

MAC-321

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00063427 - Study Evaluating MAC-321 in Colorectal Cancer | Biotech Hunter | Biotech Hunter